在使用雌二醇的绝经后妇女中产生低血栓的发生
L Morimont1,2, M Didembourg2, C Bouvy1
1QUALIresearch, Qualiblood s.a, Namur, Belgium.
Climacteric : the journal of the International Menopause Society
|January 19, 2024
概括
雌二醇 (E4) 对绝经后妇女的凝血有中性作用. 这种新型雌激素没有显著改变静血标志物,这表明它是管理血管运动症状的安全配置文件.
科学领域:
- 内分泌学 在内分泌学.
- 生殖医学 生殖医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 乙醇 (E4) 是一种用于血管运动症状的新型雌激素.
- E4激活核雌激素受体α (ERα),但对抗膜启动的通路.
- 独特的E4特性可能会导致对血液静止的低影响.
研究的目的:
- 评估E4对绝经后妇女凝血的影响.
- 利用血栓生成试验 (TGA) 来评估血液静止.
- 研究了不同口服E4剂量对凝血参数的影响.
主要方法:
- 进行了一项多中心,随机,安慰剂控制的研究 (NCT02834312).
- 绝经后的妇女每天服用口服E4 (2.5-15毫克) 或安慰剂,持续12周.
- 血小板和TGA参数在基线和12周后被分析.
主要成果:
- 所有E4治疗组的平均血小板均保持在已确定的参考范围内.
- 在所有组中,血栓生成试验参数都保持在正常范围内.
- 在E4治疗12周后,没有观察到临床相关的凝血变化.
结论:
- 口服乙醇 (E4) 在绝经后妇女的血液静止中表现为中性.
- 即使是E4的最高剂量 (15毫克) 也没有导致临床上显著的凝血变化.
- 对于治疗更年期症状而言,E4似乎是一个安全的选择,因为它有血静效应.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
701
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
701
Menopause
166
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
166
Disorders of Hemostasis
918
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
918
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K


